Pfizer, Inc. Press Releases

PFE 
$34.59
*  
0.07
0.2%
Get PFE Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk
2/26/2015 12:29:00 PM - Business Wire


Nodality Inc. Presents Data from Immuno-Oncology Program Applying Company’s Novel Single Cell Network Profiling (SCNP) Platform
2/25/2015 8:00:00 AM - Business Wire


Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2/24/2015 10:00:00 AM - Business Wire


Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2/24/2015 10:00:00 AM - Business Wire


Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBA® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diptheria And Pertussis (Tdap) Vaccines In Adolescents
2/24/2015 8:00:00 AM - Business Wire


FDA Accepts Supplemental New Drug Application for Priority Review of RAPAMUNE® (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)
2/20/2015 10:30:00 AM - Business Wire


Reality TV Star and Acclaimed Regional Mexican Female Artist Chiquis Rivera Hosts Dress Cutting Event in Miami
2/19/2015 5:36:00 PM - PR Newswire


HOSPIRA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2/18/2015 2:34:00 PM - Business Wire


HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. (HSP) Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc.
2/17/2015 7:30:00 PM - Business Wire


Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)
2/13/2015 10:27:00 AM - Business Wire


HOSPIRA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2/10/2015 4:59:00 PM - Business Wire


WeissLaw LLP: Hospira, Inc. Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP Shareholders
2/10/2015 11:00:00 AM - PR Newswire


Harwood Feffer LLP Announces Investigation of Hospira, Inc.
2/9/2015 8:05:00 PM - PR Newswire


Pfizer Commences $5 Billion Accelerated Share Repurchase
2/9/2015 5:27:00 PM - Business Wire


Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Investor Conference
2/9/2015 10:00:00 AM - Business Wire


HOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc. - HSP
2/6/2015 7:30:00 PM - PR Newswire


Ryan & Maniskas, LLP Announces Investigation of Hospira Inc.
2/6/2015 10:45:00 AM - PR Newswire


Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hospira, Inc. Stockholders
2/5/2015 6:19:00 PM - Business Wire


HOSPIRA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hospira, Inc.
2/5/2015 4:22:00 PM - PR Newswire


CVS Health Announces Data from Smoking Cessation Outreach on One-Year Anniversary of Decision to Stop Tobacco Sales
2/5/2015 12:45:00 PM - PR Newswire


Arch Coal Recognized for Operational Excellence by the State of West Virginia, Takes Home Nine Safety and Environmental Awards
2/5/2015 11:10:00 AM - PR Newswire


Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer Inc.
2/5/2015 10:08:00 AM - PR Newswire


HOSPIRA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2/5/2015 9:39:00 AM - PR Newswire


Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer’s Proposed Acquisition of Hospira
2/5/2015 7:10:00 AM - Business Wire


Pfizer To Acquire Hospira
2/5/2015 7:00:00 AM - Business Wire